r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

MP

MPM BIOVENTURES 2018, L.P.

Insider · 10% owner · TRDA

MPM BIOVENTURES 2018, L.P. files insider transactions with the SEC as a 10% owner of Entrada Therapeutics (TRDA). We hold 10 disclosed purchases and sales filed since 8 September 2021, 9 of them in the last 90 days.

  • Files forTRDA
  • Disclosed buys and sells10 in all, 9 in the last 90 days
  • Last disclosure3 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 2 November 2021 — 3 September 202610% owner · Entrada Therapeutics (TRDA)14 Form 4 lines · source: SEC Form 4
  • Filed 12 January 2026 — 12 January 202610% owner · Aktis Oncology (AKTS)7 Form 4 lines · source: SEC Form 4
  • Filed 7 September 2021 — 7 December 202110% owner · iTeos Therapeutics (ITOS)20 Form 4 lines · source: SEC Form 4

Everything they disclosed

41 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.